Big Data Analytics Research Projects Target Cancer, Genomics

Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments. Read the complete article here…

MMRF, GNS Healthcare to Collaborate on CoMMpass Study

GNS Healthcare and the Multiple Myeloma Research Foundation announced today an agreement to use GNS’ informatics solutions to explore genomic and clinical data from the Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile, or CoMMpass, study. Read the complete article here…

Strategic Investors: A Digital Health Start-Up’s Best Friend?

Although Coppedge will not disclose the total investment amount, Cambia currently has 13 start-ups in its portfolio, including data analytics company GNS Healthcare. Cambia Health Solutions came out of nowhere this past year to break into Rock Health’s ranking of top digital health investors with eight investments in 2014. The Portland, Oregon-based insurer, the only insurance company on […]

The Multiple Myeloma Research Foundation and GNS Healthcare Announce Collaboration to Identify Potential New Multiple Myeloma Therapies

Initiative will deploy predictive big data analytics to analyze patient data from landmark CoMMpass Study™ to speed drug discovery and development for patients with multiple myeloma CAMBRIDGE, Mass. and NORWALK, Conn. – Jan. 7, 2015 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, and the […]

Scientific American Worldview and Center for Medicine in the Public Interest Honor GNS Healthcare CEO and Co-Founder Colin Hill

‘Top Medical Innovators’ Honor Recognizes GNS for Work in Multiple Myeloma CAMBRIDGE, Mass. – Dec. 9, 2014 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced that its CEO and co-founder, Colin Hill, has been honored by Scientific American Worldview as a Top Medical […]

GNS Healthcare And CHDI Foundation Collaborate To Identify Novel Drug Targets For Huntington’s Disease

Scientific team using state-of-the-art technology to analyze vast dataset CAMBRIDGE, Mass. and NEW YORK CITY – Nov. 12, 2014 – GNS Healthcare (GNS), a leading provider of big data analytics in health care, announced today that CHDI Foundation, Inc. (CHDI), a privately-funded, nonprofit biomedical research organization exclusively dedicated to Huntington’s disease, has committed to continuing […]

Health Care of the Future: Big brains buoy big ideas for big data

Joe Gray, one of Oregon Health & Science University’s star cancer researchers, put it best. There’s so much data out there, sometimes it’s like “getting hit with a fire hose.” “We have to do a better job of taking the data and distilling it into information,” said Gray, who is associate director for translational research […]

Hartford Courant: Aetna Study Uses Data To Predict Risk Of Metabolic Syndrome

Aetna and a data analytics firm looked at medical claims of 37,000 policyholders to find the likelihood that those patients are at a risk of metabolic syndrome, according to research published last week in the American Journal of Managed Care. Metabolic syndrome is characterized by five factors: a large waist size, high blood pressure, high […]

Health Data Management: Biomedical Data Analyses Can Predict Metabolic Risk

Analyses of biomedical data from nearly 37,000 volunteer employees of a large company insured under Aetna shows a success rate of 80 percent to 88 percent in predicting risk of metabolic syndrome, which can cause chronic disease. Metabolic syndrome means an individual has at least three of five biological characteristics that are out of normal […]